Advanced search
Publication Cover
Autoimmunity Volume 44, 2011 - Issue 6
Submit an article Journal homepage
514
Views
76
CrossRef citations to date
0
Altmetric
Short Communication

Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis

Jide TianDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA
,
Jing YongDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA
,
Hoa DangDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA
&
Daniel L. KaufmanDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USACorrespondence[email protected]
Pages 465-470 | Received 23 Oct 2010, Accepted 09 Mar 2011, Published online: 23 May 2011

References

  • Erdo SL, Wolff JR. Gamma-aminobutyric acid outside the mammalian brain. J Neurochem. 1990; 54:363–372.
  • Tian J, Chau C, Hales TG, Kaufman DL. GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol. 1999; 96:21–28.
  • Tian J, Lu Y, Zhang H, Chau CH, Dang HN, Kaufman DL. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol. 2004; 173:5298–5304.
  • Bergeret M, Khrestchatisky M, Tremblay E, Bernard A, Gregoire A, Chany C. GABA modulates cytotoxicity of immunocompetent cells expressing GABAA receptor subunits. Biomed Pharmacother. 1998; 52:214–219.
  • Reyes-Garcia MG, Hernandez-Hernandez F, Hernandez-Tellez B, Garcia-Tamayo F. GABA(A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. J Neuroimmunol. 2007; 188:64–68.
  • Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, Steinman L. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA. 2010; 107:2580–2585.
  • Alam S, Laughton DL, Walding A, Wolstenholme AJ. Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol Immunol. 2006; 43:1432–1442.
  • Majithia V, Geraci SA. Rheumatoid arthritis: Diagnosis and management. Am J Med. 2007; 120:936–939.
  • Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol. 2009; 4:417–434.
  • O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004; 350:2591–2602.
  • Hasler P. Biological therapies directed against cells in autoimmune disease. Springer Semin Immunopathol. 2006; 27:443–456.
  • Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev. 1990; 118:193–232.
  • Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997; 61:1861–1878.
  • Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y, Sarvetnick N, Tobin AJ, Lehmann PV, Kaufman DL. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med. 1996; 2:1348–1353.
  • Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med. 1996; 183:1561–1567.
  • Harris EDJr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990; 322:1277–1289.
  • Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?. Arthritis Rheum. 1997; 40:5–18.
  • Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003; 423:356–361.
  • Stuart JM, Dixon FJ:. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983; 158:378–392.
  • Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006; 6:394–403.
  • Otomo E, Araki G, Mori A, Kurihara M. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. Arzneimittelforschung. 1981; 31:1511–1523.
  • Loeb C, Benassi E, Bo GP, Cocito L, Maffini M, Scotto P. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Res. 1987; 1:209–212.
  • . 1960. Inhibition in the nervous system and GABATower DB, Roberts E. New York: Pergamon Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.